Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Review ArticleReview

Role of Adiponectin and Its Receptors in Cancer

Stephanie Obeid and Lionel Hebbard
Cancer Biology & Medicine December 2012, 9 (4) 213-220; DOI: https://doi.org/10.7497/j.issn.2095-3941.2012.04.001
Stephanie Obeid
1Storr Liver Unit, Westmead Millennium Institute, PO Box 412, Darcy Road, Westmead, NSW 2145, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lionel Hebbard
1Storr Liver Unit, Westmead Millennium Institute, PO Box 412, Darcy Road, Westmead, NSW 2145, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lionel.hebbard{at}sydney.edu.au
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    In vivo models supporting the role of APN in cancer.

    CancerModelReference
    Breast cancerNude mouse model; MDA-MB-231 cells treated with and without APNWang et al.[52]
    PyMT oncogene expressed by MMTV bred into the APN backgroundDenzel et al.[61]
    Colorectal cancerSyngeneic mouse model; CRC cell line MCA38 injected into APN-null mice and wild-type mice on a high-fat dietMoon et al.[89]
    Spontaneous tumor progression; Azoxymethane injections weekly in APN-null mice and wildtype miceNishihara et al.[90]
    Chronic inflammation-induced CRC; three cycles of dextran sulfate sodium administration into APN-/- mice and wild-type mice, followed by weekly doses of 1,2-dimethylhydrazine for 12 weeks, followed by 3 cycles of DSSSaxena et al.[66]
    Liver cancerOrthotoptic liver cancer model; MHCC97L cells subcutaneously injected into nude miceMan et al.[72]
    Nude mouse xenograft model of HCC; subcutaneous injection of HepG2 cells, followed by intraperitoneal injections of leptin and adiponectinSharma et al.[31]
    Hematological cancerMultiple myeloma model; wild-type and APN-null mice intravenously treated with 5TGM1-GFP cellsFowler et al.[91]
    Gastric cancerNude mouse model; subcutaneous injection of AZ521 cells, followed by APN intratumoral injectionIshikawa et al.[92]
    • View popup
    Table 2.

    Clinical studies on the role of APN in human cancer.

    CancerAPN serum concentration
    Breast cancerDecreased [39,48,55–57]
    Colorectal cancerDecreased [47,63,93]
    Pancreatic cancerDecreased [44,73,94]
    Endometrial cancerDecreased [40,76,95]
    Prostate cancerDecreased [41,73]
    Gastric cancerDecreased [42]
    Liver cancerDecreased [43]
    Hematological cancerDecreased [46,80,81,86]
PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 9 (4)
Cancer Biology & Medicine
Vol. 9, Issue 4
1 Dec 2012
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role of Adiponectin and Its Receptors in Cancer
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Role of Adiponectin and Its Receptors in Cancer
Stephanie Obeid, Lionel Hebbard
Cancer Biology & Medicine Dec 2012, 9 (4) 213-220; DOI: 10.7497/j.issn.2095-3941.2012.04.001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Role of Adiponectin and Its Receptors in Cancer
Stephanie Obeid, Lionel Hebbard
Cancer Biology & Medicine Dec 2012, 9 (4) 213-220; DOI: 10.7497/j.issn.2095-3941.2012.04.001
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Adiponectin Structure
    • Adiponectin Receptors
    • Adiponectin Signaling Pathways in Cancer
    • Adiponectin and Cancer
    • Hematological cancer
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Aberrant control of NF-{kappa}B in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode
  • Evolving role of adiponectin in cancer-controversies and update
  • Google Scholar

More in this TOC Section

  • Pyroptosis in cancer: a dual regulator of tumor cell fate and immune activation
  • Treatment implications of T cell DNA damage in anti-tumor immunity
  • Non-coding RNA delivery via lipid nanoparticles: a novel strategy for cancer immunotherapy
Show more Review

Similar Articles

Keywords

  • adiponectin
  • cancer
  • signaling

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire